Gates Package — page 207

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl 2015-33635 _| Research Collaboration Agreement 4/20/2016} 4/20/2021|Kobe University Graduate School of Medicine [JP] _ |Jeffrey Cohen 2015-33646 'I Letter of Intent/MOU 12/14/2015 GeoVax, Inc. Heinrich Feldmanr| 2015-33652 Gift 6/21/2016] 6/21/2018]Ohio State University Jesus Valenzuela Millennium Pharmaceuticals, Inc., TAKEDA 2015-33660 _|CTA- Clinical Trial Agreement 8/15/2016} PHARMACEUTICAL COMPANY, LTD. Millennium Pharmaceuticals, Inc., TAKEDA 2015-33660 _|CTA- Clinical Trial Agreement 8/15/2016 PHARMACEUTICAL COMPANY, LTD. Millennium Pharmaceuticals, Inc., TAKEDA 2015-33660 _|CTA- Clinical Trial Agreement 8/15/2016} PHARMACEUTICAL COMPANY, LTD. 2015-33666 Research Collaboration Agreement 2/15/2016] 2/15/2022] University of Minnesota Edward Berger 2015-33678 |Gift 1/20/2016| 12/31/2016] Histiocytosis Association Konrad Krzewski 2015-33678 |Gift 1/20/2016] 12/31/2016] Histiocytosis Association Konrad Krzewski 2015-33685 Research Collaboration Agreement 6/9/2016} 6/9/2021] Genocea Biosciences, Inc. Jeffrey Cohen GlaxoSmithKline Investigacion y Desarrollo (GSK) 2015-33699 |CRADA 2/22/2016} 2/22/2019} [ES] Clifton Barry 2015-33700 _ |Research Collaboration Agreement 1/23/2016} _1/23/2022|Food and Drug Administration (FDA) Jesus Valenzuela French Institute of Health and Medical Research (INSERM, Institut National de la, London School of Hygiene & Tropical Medicine (LSHTM) (University 2015-33704 I CTA- Clinical Trial Agreement 1/23/2017 of London) [GB] H Clifford Lane GlaxoSmithKline (GSK), PATH Malaria Vaccine 2015-33706 _| Research Collaboration Agreement 1/29/2016] 1/29/2021||Initiative (MVI) [US] Patrick Duffy 2015-33710 {Gift 7/15/2016] 7/15/2017]Yale University Jesus Valenzuela 2015-33722 _|CRADA 12/22/2016| 9/22/2019} Pfizer, Inc. 2015-33722 _|CRADA 12/22/2016| 9/22/2019} Pfizer, Inc. 2016-0025 Research Collaboration Agreement 2/5/2016 Albert Einstein College of Medicine, Inc. [US] Peter Jahrling Bavarian Nordic A/S [DK], Janssen Vaccines & Prevention B.V. (part of Johnson & Johnson; J&J) 2016-0032 CTA - Clinical Trial Agreement 12/9/2016 [NL] H Clifford Lane 2016-0033 Research Collaboration Agreement 7/18/2016] 7/18/2021] University of Dundee [GB] Mark Connors 2016-0036 Gift 3/25/2016 Creutzfeldt-Jakob Disease (CJD) Foundation, Inc. Byron Caughey 2016-0069 CTA - Clinical Trial Agreement 1/5/2017 Merck Sharp & Dohme Corp H Clifford Lane 2016-0070 CRADA 7/14/2017| 7/14/2020] Sanofi US Services Inc. Jeffrey Cohen